Gary M. Clark
Impact in
- Oncology top 0.01%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 0.01%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Breast Cancer Treatment Studies 55
- Cancer Genomics and Diagnostics 21
- Oncology 135
- HER2/EGFR in Cancer Research 48
- Cancer Treatment and Pharmacology 23
- Cancer-related Molecular Pathways 14
- Co-authors
- William McGuireDennis J. SlamonAxel UllrichWendy J. LevinSteven WongC. Kent OsborneLisa M. McShaneD. Craig Allred
- Journals
- Journal of Clinical Oncology (30 papers)Breast Cancer Research and Treatment (26 papers)JNCI Journal of the National Cancer Institute (20 papers)Cancer (13 papers)Anti-Cancer Drugs (7 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Gary M. Clark
270 papers receiving 43.1k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Oncology 28.3k
- Cancer Research 14.5k
- Pulmonary and Respiratory Medicine 10.6k
- Radiology, Nuclear Medicine and Imaging 7.1k
- Pathology and Forensic Medicine 5.0k
Countries citing papers authored by Gary M. Clark
This map shows the geographic impact of Gary M. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary M. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary M. Clark more than expected).
Fields of papers citing papers by Gary M. Clark
This network shows the impact of papers produced by Gary M. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary M. Clark. The network helps show where Gary M. Clark may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gary M. Clark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 8 | |
| 2 | 2009 | 83 | |
| 3 | 2005 | 65 | |
| 4 | Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. | 2002 | 244 |
| 5 | Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer Hit paper breakdown → | 1999 | 1630 |
| 6 | HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study. | 1998 | 203 |
| 7 | Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study). | 1998 | 38 |
| 8 | 1994 | 357 | |
| 9 | 1994 | 47 | |
| 10 | 1994 | 10 | |
| 11 | Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques. | 1993 | 49 |
| 12 | 1992 | 329 | |
| 13 | 1992 | 92 | |
| 14 | Epidermal growth factor receptor amplification in head and neck cancer | 1991 | 9 |
| 15 | HER-2/neu amplification predicts poor survival in node-positive breast cancer. | 1990 | 393 |
| 16 | 1990 | 258 | |
| 17 | 1989 | 47 | |
| 18 | 1989 | 2 | |
| 19 | Pancreatic cancer treated with carmustine, fluorouracil, and spironolactone: a randomized study. | 1978 | 6 |
| 20 | Clinical significance of the isomorphic pattern of the isoenzymes of serum lactate dehydrogenase. | 1977 | 9 |
About Gary M. Clark
Gary M. Clark is a scholar working on Cancer Research, Oncology, Statistics and Probability, Complementary and Manual Therapy and Orthodontics, having authored 274 papers that have together received 44.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (55 papers), HER2/EGFR in Cancer Research (48 papers), Estrogen and related hormone effects (33 papers), Lung Cancer Treatments and Mutations (24 papers), Cancer Treatment and Pharmacology (23 papers), Cancer Genomics and Diagnostics (21 papers), Statistical Methods in Clinical Trials (17 papers) and Cancer-related Molecular Pathways (14 papers). The work is most often cited by research in Oncology (28.3k citations), Cancer Research (14.5k citations), Pulmonary and Respiratory Medicine (10.6k citations), Radiology, Nuclear Medicine and Imaging (7.1k citations) and Pathology and Forensic Medicine (5.0k citations). Gary M. Clark has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include William McGuire, Dennis J. Slamon, Axel Ullrich, Wendy J. Levin, Steven Wong, C. Kent Osborne, Lisa M. McShane, D. Craig Allred, Sheila E. Taube and Willi Sauerbrei. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, JNCI Journal of the National Cancer Institute, Cancer and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.